InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,570.75
(
0.06%
)
US TECH 100
19,866.41
(
0.10%
)
Dow Jones
39,331.32
(
-0.11%
)
Brent Oil
85.52
(
-1.14%
)
Bitcoin
56,375.17
(
0.95%
)
Post# of 179946
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Drannac

Send PM Follow Ignore
Followers 7
Posts 1957
Boards Moderated 0
Alias Born 05/19/2015

Drannac

Re: Brazman post# 169133

Wednesday, 07/03/2019 10:26:01 AM

Wednesday, July 03, 2019 10:26:01 AM

Post# of 179946
I suspect that POTN is in a quiet period waiting for the SEC and uplist evaluations to be completed. It is wise to avoid PRs that could cause any problems. At my pharma company, we were told not to speak of our research to anybody outside of the company while waiting for FDA approval of IND status for a clinical trial.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up